Top Tweets for #FallClinical
Have you seen the latest interview with @drshawnkwatra from #FallClinical?🎥
In this discussion, Dr. Kwatra spoke about several key highlights from his sessions discussing atopic dermatitis, prurigo nodularis, and the OX40 ligand (OX40L).
🔗View here:
https://t.co/nVbaxYBcpz
At the 2025 #FallClinical Dermatology Conference @RajMDPhD, of @RFUniversity, co-presented a session titled ‘Shifting the Management Paradigm in Generalized Pustular Psoriasis.’💡
🎥In a recent interview, Dr. Chovatiya spoke about the major takeaways:
https://t.co/twmds0qePa
ICYMI: At #FallClinical, Lisa A. Swanson, MD, of Ada West Dermatology, highlighted the potential @US_FDA approval of icotrokinra allowing for an oral alternative for #psoriasis treatment to injectable, IL-23 inhibitors.🎥
🔗View her on-site discussion:
https://t.co/oUhwJR7Pm2
ICYMI: At #FallClinical, a session titled ‘Bullous Pemphigoid: The Time to Treat is Now’ was presented.
HCPLive spoke with presenter Prince Adotama, MD, of @nyugrossman about takeaways from this talk.
View: https://t.co/IvKMTDf9vI
Mark S. Nestor, MD, PhD, spoke in a recent interview on-site at #FallClinical with HCPLive regarding one of his presentations at the meeting titled ‘The Reality of Actinic Keratosis: Centering Patient Experiences and Real-World Evidence.’
View more here:
https://t.co/wA1N8AVQu4
ICYMI: In the CHECK study, a cross-sectional survey of over 10K participants, the US prevalence of chronic hand #eczema (CHE) was highlighted.💡These data & others on CHE were announced by @LEOPharmaUS & presented at #FallClinical.
🔗View more here:
https://t.co/1INYlm8uK1
ICYMI: At #FallClinical, Lisa A. Swanson, MD, of Ada West Dermatology, highlighted the potential @US_FDA approval of icotrokinra allowing for an oral alternative for #psoriasis treatment to injectable, IL-23 inhibitors.🎥
🔗View her on-site discussion:
https://t.co/oUhwJR7Pm2
At #FallClinical, Lisa A. Swanson, MD, of Ada West Dermatology, highlighted the potential @US_FDA approval of icotrokinra allowing for an oral alternative for #psoriasis treatment to injectable, IL-23 inhibitors.🎥
🔗View her on-site discussion:
https://t.co/6qcBmNDurc
ICYMI: Have you seen the latest interview at #FallClinical with Prince Adotama, MD, of @nyugrossman?🎥
Learn about the FDA approval of #dupilumab and other new developments in the #BullousPemphigoid treatment space...🌟
🔗View: https://t.co/u66A7ytb5I
Dr. Eingun James Song of Frontier Dermatology spoke at #FallClinical about the @IpcPs decision to recommend re-categorization of psoriasis severity to being a topical or systemic patient.
Want to learn more about his session on IL-23 inhibitors?
🔗View:
https://t.co/o7T4JTWAzp
Are you up-to-date on the latest coverage of the #FallClinical dermatology conference in Las Vegas?🔍
💡To stay informed about recent findings in skin health and on interviews with leaders in the field, view the latest news here:
https://t.co/Qvx2nQpKZ7
In his #FallClinical interview on-site in Las Vegas, Andrew Alexis, MD, MPH, of @WeillCornell, interviewed with HCPLive regarding his talk ‘Melasma and Other Hyperpigmentation Disorders.’🎥
Want to learn more?
🔗View his discussion here:
https://t.co/VfFmVABR29
In an interview at #FallClinical, we spoke with Andrew Alexis, MD, MPH, of @WeillCornell on his portion of a talk titled ‘30 Tips in 30 Minutes.’🎥
💡He discusses 2 helpful tips in treating keloids and #acne. Learn more here: https://t.co/Nm7hThGcar
ICYMI: Have you seen the latest interview at #FallClinical with Dr. Prince Adotama of @nyugrossman?🎥
Check it out with the link below to learn about the FDA approval of #dupilumab and other developments in the bullous pemphigoid treatment space.
🔗View: https://t.co/IvKMTDfHlg
Have you caught up with the latest coverage of #FallClinical?
Check out our coverage page for any updates on new data in #dermatology and interviews with leaders in the field.💡
🔗View: https://t.co/Qvx2nQpKZ7
At #FallClinical:
New data suggests DFD-29 demonstrated superior efficacy over doxycycline and placebo in treating papulopustular #rosacea, with significant improvements in IGA success and lesion reduction. Want to learn more?💡
🔗View our summary: https://t.co/uvwSFNaBvr
At the 2025 #FallClinical Dermatology conference, session presenter Mark S. Nestor, MD, PhD, presented a talk titled ‘What Did 2025 Bring to the Table in Dermatology?’💡
🔗He spoke with us about the biggest takeaways. View here: https://t.co/OrvWTruzLV
At #FallClinical, new data showed lebrikizumab (Ebglyss) in #AtopicDermatitis resulted in durable disease control when used once every 8 weeks.
These data, released by @JNJNews, highlight the potential for a less frequent dosing regimen for lebrikizumab.
https://t.co/pOr6dO7DbT
HCPLive is on-site here in Las Vegas!🎲
Here at the 2025 #FallClinical Dermatology meeting, we're covering new sessions, recent data, and interviews with experts in the field. Don't miss updates on this conference and new data!💡
🔗View updates here: https://t.co/Qvx2nQqiOF
At #FallClinical in Las Vegas:
Christopher Bunick, MD, PhD, of @yalederm spoke with our team about important safety considerations for corticosteroids and JAK inhibitors.
🎥Check out the full interview here: https://t.co/QwDngeP8mw
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.7M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.4M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.2M followers
Taylor Swift
@taylorswift13
81M followers
Lady Gaga
@ladygaga
72.6M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.2M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.8M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.3M followers